1. Home
  2. HUBC vs DCOY Comparison

HUBC vs DCOY Comparison

Compare HUBC & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hub Cyber Security Ltd.

HUBC

Hub Cyber Security Ltd.

HOLD

Current Price

$0.09

Market Cap

2.8M

Sector

N/A

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.47

Market Cap

3.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUBC
DCOY
Founded
2017
N/A
Country
Israel
United States
Employees
322
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HUBC
DCOY
Price
$0.09
$6.47
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
12.1M
37.6K
Earning Date
04-30-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.53
52 Week High
$5.09
$9.09

Technical Indicators

Market Signals
Indicator
HUBC
DCOY
Relative Strength Index (RSI) 24.79 52.66
Support Level N/A $0.61
Resistance Level $0.50 $7.50
Average True Range (ATR) 0.08 0.63
MACD 0.03 -0.38
Stochastic Oscillator 6.15 7.17

Price Performance

Historical Comparison
HUBC
DCOY

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers.

Share on Social Networks: